When do Human Chorionic Gonadotropin (HCG) levels drop after a dilation and curettage (D&C) procedure at 8 weeks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HCG Level Decline After D&C at 8 Weeks

After a D&C procedure at 8 weeks gestation, HCG levels typically decline rapidly, with a 70% decrease by day 3 and over 90% decrease by day 5 post-procedure. 1

Normal HCG Clearance Pattern

  • HCG follows a predictable decline after uterine evacuation procedures such as D&C 1, 2
  • The initial decline is rapid, with a half-life of approximately 0.63 days in the first 2 days following the procedure 2
  • By day 3 post-procedure, expect approximately a 70% (±10.6%) decrease from the initial HCG level 1
  • By day 5 post-procedure, expect approximately a 91.4% (±4.4%) decrease from the initial HCG level 1
  • By days 7-9, HCG levels typically decline by 97.1% (±1.7%) from the initial value 1
  • A complete return to non-pregnant levels (undetectable HCG) typically occurs within 2 weeks after the procedure for most women 2

Monitoring Recommendations

  • For normal pregnancies terminated by D&C, a single HCG test 2 weeks after the procedure should be sufficient to confirm complete evacuation 2
  • If the urine pregnancy test remains positive 4 weeks after the procedure, this may indicate incomplete evacuation or persistent trophoblastic tissue 2

Special Considerations for Molar Pregnancies

  • If the D&C was performed for a hydatidiform mole, more intensive HCG monitoring is required 3, 4
  • For partial hydatidiform moles, weekly HCG measurements are recommended until there are two consecutive undetectable values 4
  • For complete hydatidiform moles, weekly HCG measurements until normalization followed by monthly monitoring for 6 months is recommended 3, 4
  • Plateauing or rising HCG levels after molar pregnancy treatment suggests development of gestational trophoblastic neoplasia (GTN) and requires immediate evaluation 3

Factors That May Affect HCG Decline

  • The rate of HCG decline is generally not affected by the initial HCG level or gestational duration 1
  • Later implantation pregnancies (those that implanted after day 10 of the luteal phase) may show a slightly slower rate of HCG decline 5
  • The presence of retained products of conception can slow the decline of HCG levels 2

Warning Signs Requiring Further Evaluation

  • If HCG levels plateau (less than 10% fall over three consecutive measurements) or begin to rise after initial decline, this may indicate incomplete evacuation or persistent trophoblastic disease 3, 6
  • A positive pregnancy test 4 weeks after D&C warrants further investigation for retained products of conception or persistent trophoblastic tissue 2
  • If HCG remains detectable for longer than 6 months after D&C for molar pregnancy, this meets the definition of persistent trophoblastic disease and requires oncologic referral 4

Practical Guidance

  • For women who need confirmation of complete evacuation sooner than 1 week after the procedure, a single repeat HCG on day 5 may be clinically useful 1
  • A urine pregnancy test with a sensitivity of 1 IU/ml will typically be negative within 2 weeks after a complete evacuation 2
  • Safe contraception should be used during the HCG monitoring period, especially after molar pregnancy 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.